Literature DB >> 24712011

A 29-year-old man with hospital-acquired cavitary pneumonia.

Mansoor Mehmood, Ruba A Halloush, Faisal A Khasawneh.   

Abstract

Cavitary lung processes pose a formidable diagnostic challenge. Causes vary widely and include cavitary pneumonia, vasculitis and malignancy. In some cases, patient history and basic work-up may yield a diagnosis, but in others, an extensive work-up, including tissue biopsy, may be necessary to establish the cause. The authors present a case of cavitary pneumonia that complicated an open lung biopsy. It developed in the hospital and was caused by mucormycosis, a potential emerging infection causing health care-associated infections.

Entities:  

Mesh:

Year:  2014        PMID: 24712011      PMCID: PMC4173885          DOI: 10.1155/2014/614148

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  13 in total

1.  Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy.

Authors:  Olivier Brugière; Gaëlle Dauriat; Hervé Mal; Rolana Marrash-Chalha; Michel Fournier; Odile Groussard; Mathieu Besnard; Guy Lesèche; Bertrand Dupont
Journal:  Transplantation       Date:  2005-11-15       Impact factor: 4.939

2.  Disseminated mucormycosis due to Cunninghamella bertholletiae in a liver transplant recipient.

Authors:  G R Nimmo; R F Whiting; R W Strong
Journal:  Postgrad Med J       Date:  1988-01       Impact factor: 2.401

Review 3.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

Review 4.  Epidemiology and clinical manifestations of mucormycosis.

Authors:  George Petrikkos; Anna Skiada; Olivier Lortholary; Emmanuel Roilides; Thomas J Walsh; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

Review 5.  Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives.

Authors:  Kyung J Kwon-Chung
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

6.  Cluster of pulmonary infections caused by Cunninghamella bertholletiae in immunocompromised patients.

Authors:  V Rickerts; A Böhme; A Viertel; G Behrendt; V Jacobi; K Tintelnot; G Just-Nübling
Journal:  Clin Infect Dis       Date:  2000-10-11       Impact factor: 9.079

7.  Activity of posaconazole in treatment of experimental disseminated zygomycosis.

Authors:  Eric Dannaoui; Jacques F G M Meis; David Loebenberg; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

8.  Nosocomial fungal infection during hospital renovation.

Authors:  K Krasinski; R S Holzman; B Hanna; M A Greco; M Graff; M Bhogal
Journal:  Infect Control       Date:  1985-07

9.  Pleural mucormycosis (zygomycosis).

Authors:  W R Green; D Bouchette
Journal:  Arch Pathol Lab Med       Date:  1986-05       Impact factor: 5.534

10.  Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis.

Authors:  Caitlin Reed; Richard Bryant; Ashraf S Ibrahim; John Edwards; Scott G Filler; Robert Goldberg; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.